Equity · Healthcare
RMTI
NASDAQRockwell Medical (RMTI)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Market cap
- 24.9M USD
- Revenue, year to Dec 2025
- 69.3M USD
- EPS, diluted, year to Dec 2025
- −0.15 USD
- 52-week range
- 5.20 USD – 20 USD
- Avg volume
- 3.8K
as of Jul 17, 2026
Have Rockwell Medical (RMTI) insiders bought or sold shares recently?
In the 90 days to 11 Nov 2026, Rockwell Medical insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 17 Nov 2025, show no open-market purchase.
Form 4, 90 days to 11 Nov 2026, newest reported trade 1 Oct 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 01 Oct 2026 | Strobeck MarkPresident and CEO | Sell | 1,000 | 8K USD |
Which funds hold Rockwell Medical (RMTI)?
1 of the 45 institutional funds we track reported a Rockwell Medical position for the quarter ended 30 Jun 2026 — a combined 198K USD; the latest of those filings landed 13 Aug 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Renaissance Technologies | Trimmed | 359,672 | 198K USD | −43.7% |
What has been filed or recorded for Rockwell Medical (RMTI)?
The filings we hold for Rockwell Medical, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,306 shares | 10K USD notional · 0.032% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 330 shares | 3K USD notional · 0.008% of shares out |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 799 shares | 7K USD notional · 0.020% of shares out |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 199 shares | 2K USD notional · 0.005% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.74 USD | |
| 30 Jun 2026 | Financials | Total assets | 56.5M USD | at period end |
| 30 Jun 2026 | Financials | Total equity | 35.1M USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.04 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.15 USD | |
| 31 Dec 2025 | Financials | Revenue | 69.3M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −5.3M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −0.15 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.05 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.05 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.04 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −0.03 USD | |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS 0.04 USD |
What do people ask about Rockwell Medical (RMTI)?
What is Rockwell Medical’s market cap?24.9M
Rockwell Medical is worth 24.9M USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.
What is Rockwell Medical’s revenue?69.3M
Rockwell Medical reported revenue of 69.3M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Rockwell Medical insiders bought or sold shares recently?1 sale
In the 90 days to 11 Nov 2026, Rockwell Medical insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 17 Nov 2025, show no open-market purchase. See Insiders
Which funds own Rockwell Medical?1 of 45
1 of the 45 funds we track reported a Rockwell Medical position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported position was Renaissance Technologies. See Funds
When did Rockwell Medical last report earnings?−0.74
Rockwell Medical last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.74 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings